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Abstract
Building better models of cellular pathways is one of the major
challenges of systems biology and functional genomics. There is a need
for methods to build on established expert knowledge and reconcile it
with results of high-throughput studies. Moreover, the available data
sources are heterogeneous and need to be combined in a way specific
for the part of the pathway in which they are most informative. Here,
we present a compartment specific strategy to integrate edge, node
and path data for the refinement of a network hypothesis. Specifically,
we use a local-move Gibbs sampler for refining pathway hypotheses
from a compendium of heterogeneous data sources, including novel
methodology for integrating protein attributes. We demonstrate the
utility of this approach in a case study of the pheromone response
MAPK pathway in the yeast S. cerevisiae.
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1 Introduction
Cellular mechanisms are driven by interactions between DNA, RNA, and
proteins working together in cellular pathways. However, the current knowl-
edge of information flow in the cell is still very incomplete (Kirouac et al.,
2012). Even in well established signaling pathways studied for decades in
model organisms, newer approaches can discover novel components (Mu¨ller
et al., 2005) or cross-talk with other pathways (McClean et al., 2007). In can-
cer, finding pathways underlying disease development can lead to new drug
targets (Balbin et al., 2013). This makes the dissection of cellular pathways
one of the major challenges of systems biology and functional genomics.
One of the main obstacles to utilize high-throughput data in refining
known pathway models is the gap between the relatively unbiased and hypothesis-
free nature of generating genome-scale datasets and the need for very focused,
hypothesis-driven research to test biological models in small or medium scale
experiments (Hibbs et al., 2008). While researchers in computational biology
usually start with a collection of data and reconstruct pathways from it, ex-
perimental biologists often start with a specific pathway hypothesis in mind
and try to reconcile it with the evidence from high-throughput screens.
Here, we contribute to bridging this gap by introducing a comprehensive
data integration strategy to refine a given pathway hypothesis. Our approach
is characterized by three key features: First, we start with a specific pathway
model and assess how well it is supported in a collection of complementary
data sets. These data sets are heterogeneous and informative for distinct
cellular locations. Second, we exploit this fact by introducing a compartment-
specific probabilistic model, where data types are only used for reconstructing
the parts of a pathway they are informative about. Third, we explicitly
include node properties in our model. This allows us to use data like protein
phosphorylation states or protein domains, which have so far been under-
utilized for pathway structure learning (Ryan et al., 2013).
In this paper we show that our modeling approach can assist experimen-
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talists in planning future studies by assessing which parts of a biological
model are not well supported by data, and by proposing testable extensions
and refinements of a given pathway hypotheses. We demonstrate the power
of our approach in a case study in the yeast S. cerevisiae.
Related work. Pathway reconstruction is a well established field in compu-
tational biology (Hyduke and Palsson, 2010; Markowetz and Spang, 2007).
Several features distinguish our pathway refinement methodology from ex-
isting network reconstruction methods.
Comprehensive data integration strategies on large data collections were
shown to be very successful in predicting protein function and interactions
(Guan et al., 2012; Llewellyn and Eisenberg, 2008; Guan et al., 2008; My-
ers et al., 2005). These methods are very helpful for describing the global
landscape of protein function, but offer less insight into individual molec-
ular mechanisms and pathways. Our approach differs from methods to re-
fine pathway hypotheses from expression profiles of down-stream regulated
genes (Gat-Viks and Shamir, 2007), because we integrate heterogeneous data
sources in a compartment-specific way.
We also differ from previous research on de-novo pathway reconstruction.
These methods can be classified by how they use information about edges,
paths and nodes in the pathway diagram for structure learning.
• Most approaches incorporate evidence for individual edges in the path-
way diagram using phenotypic profiles (Mulder et al., 2012; Wang et al.,
2012) or gene expression measurements (Li et al., 2013; Balbin et al., 2013;
Scha¨fer and Strimmer, 2005a; Friedman, 2004; Segal et al., 2003), some-
times supplemented by additional data sources like transcription factor
binding data (Bernard and Hartemink, 2005; Werhli and Husmeier, 2007)
or protein-protein interactions (Gitter et al., 2013; Nariai et al., 2004; Segal
et al., 2003). Other studies completely rely on protein-protein interactions
to predict pathways (Mazza et al., 2013; Scott et al., 2006).
• Cause-effect relationships indicating paths from perturbed genes to ob-
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served effects are exploited in methods like SPINE (Ourfali et al., 2007),
physical network models (Yeang et al., 2005), nested effects models (Wang
et al., 2013; Markowetz et al., 2007; Tresch and Markowetz, 2008; Fro¨hlich
et al., 2007, 2008) and others (Lo et al., 2012; Yip et al., 2010), with appli-
cations including DNA damage repair (Workman et al., 2006) and cancer
signalling (Knapp and Kaderali, 2013; Stelniec-Klotz et al., 2012).
• Node information, i.e. features of individual proteins or genes, has been
found useful for assigning proteins to pathways (Hahne et al., 2008; Fro¨hlich
et al., 2008) but has so far been under-utilized in reconstructing pathway
structure (Ryan et al., 2013).
Our method differs from de-novo pathway reconstruction in that we start
with a hypothesis pathway and identify which hypothesized edges are sup-
ported by the data. We also differ from other methods which evaluate formal
one and two sample network hypothesis tests (Yates and Mukhopadhyay,
2013). Our goal is not to explicitly to determine whether our initial hy-
pothesis is “correct”– on the contrary we assume a priori that any initial
hypothesis can be further refined and improved upon. In the spirit of FDR,
we provide a list of edge probabilities that can assist experimentalists in their
future studies. We assess which parts of an existing biological model are not
well supported by a data as well as suggesting new edges which are supported
by the data but which are not part of the original hypothesis. Further, we
are the first to integrate data about edges and paths as well as nodes in the
pathway diagram.
Overview. We describe a compartment-specific probabilistic graphical
model for posterior inference on cellular pathways in section 2, which can
extend and refine a given biological model and predict novel parts of the
pathway graph. Our model comprehensively integrates the three general
types of data on edges, paths, and nodes. We demonstrate the utility of our
methods in a case study in S. Cerevisae (section 3) by first exploring the in-
formation content in different data sources individually (section 3.1) and then
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evaluating results of posterior draws using both full data and leave-one-out
data (section 3.2).
2 Integating high-dimensional responses of a
cellular pathway
Given a set of a gene products, i.e., putative pathway members, we infer an
undirected network model using a local-move Gibbs sampler. The pathway
model, is defined in terms of N nodes and the edges between these pairs
of nodes, (n,m). The edges are encoded by a binary random variable, Xnm.
The collection of edge-specific random variables defines the adjacency matrix,
X, of the pathway model.
Parameter estimation and posterior inference. The adjacency matrix X
corresponding to the pathway model is latent since we cannot directly ob-
serve the edges. Thus, the primary goal of our analysis is to do posterior
inference on the adjacency matrix, X, from a collection of M data sets, Y1:M .
Although we treat X as latent, we differ from de-novo pathway reconstruc-
tion by incorportaing an informative hypothesis pathway which we use to
train the models for data sets Y1:M (see Section 3).
By Bayes rule, the posterior distribution on a pathway model,
P (X | Y1:M ,Θ) ∝ P (X | Θ) · P (Y1:M | X,Θ), (2.1)
is proportional to the prior distribution on the pathway with the likelihood
of the data. Here, Θ is a collection of prior parameters introduced below.
We use a local Gibbs sampling strategy to sample pathway models from
posterior distribution in Equation 2.1. The sampler explores the space of
pathway models by adding or removing edges in turn, one at a time. Specif-
ically, the edge Xnm between gene products (n,m) is sampled according to a
Bernoulli distribution, with probability of success
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P (Xnm | X(−nm), Y1:M ,Θ), (2.2)
where X(−nm) represents the set of edges without Xnm.
2.1 A compartment map defines context-specific data
contributions
We use five complementary data types: physical binding of protein pairs (in-
cluding yeast-two hybrid, mass spectrometry, and literature-curated data),
transcription factor-DNA binding assays, gene knockout data, gene co-expression
data, and node information (including protein domains and differential phos-
phorylation arrays) Importantly, different data sets can be very informative
in specific cellular locations while completely uninformative in others. Thus,
before we define the data likelihoods in section 2.2, it is essential to exploit
this fact in our model. We translate expected compartment localization of
a pair of gene products (n,m) into a binary importance vector ~bnm, which
drives the inference process by selecting the most informative data types for
the compartments involved.
To instantiate the notion that different data are informative in different
cellular locations, we introduce an additional modeling element: the compart-
ment map, which contains three conceptual pathway compartments directly
based on the organisation of the cell: First, the cell membrane, where recep-
tor proteins sense signals from outside the cell; second, the cytoplasm, where
protein cascades relay these signals to transcription factor proteins that en-
ter the third compartment, the nucleus, to regulate the activity of target
genes. The compartment map, C, is a 5×3 binary matrix that associates the
three pathway compartments with the five data types to indicate which data
type is informative about molecular interactions in which compartments (see
Table 1).
In particular, each data set is described by a pair (Yi, Ti), where Yi denotes
5
the collection of measurements, and Ti is five-level factor that denotes the
specific data type used to collect the data and indexes the relevant row of C.
We can now revise the form of the conditional distributions in Equation 2.2,
P (Xnm | X(−nm), Y1:M , T1:M , C,Θ) = (2.3)
=
L(Xnm = 1, X(−nm) | Y1:M ,Θ)
L(Xnm = 1, X(−nm)|Y1:M ,Θ) + L(Xnm = 0, X(−nm)|Y1:M ,Θ)
Overloading notation, we let Ct(n,m) be an indicator reflecting whether
the protein pair (n,m) is informative for data type t, based on the com-
partment map and the localizations of proteins n and m. This leads to the
following likelihood specification:
L(Xnm, X(−nm) | Y1:M ,Θ) ∝ (2.4)
=
M∏
k
[
P (Yk | Xnm, X(−nm), Tk = t,Θ)Ct(n,m)
× P (Yk | X(−nm), Tk = t,Θ)1−Ct(n,m)
]
(2.5)
where the role of the indicator is to discard data collections from data types
that are expected to carry little information about the protein pair of interest,
according to information in C. That is, for any pair (n,m), Ct(n,m) = 0
implies data set Yk is conditionally independent of (n,m) given the rest of
the pathway. In this case, the data in Yk has no effect on the conditional
posterior probability of Xnm.
2.2 Modeling high-dimensional data for nodes, edges
and paths
Data of different types need to be modeled differently. We focus on modeling
five main data types: protein interaction data, protein-DNA binding data,
gene co-expression data, gene perturbation data, and node attribute data
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(differential phosphorylation and protein domains). Below, we describe the
likelihood functions corresponding to the main data types of interest.
Likelihood for protein interaction data. Here, we consider a single data
set YN×N obtained with data type T aimed at measuring physical protein
binding events (PPI). We reduce the likelihood of the data, Y , to a function
the false positive and false negative rates, α and β. Given the pathway, X,
we evaluate
Lppi(Y | X,α, β) = αS10(1− α)S11βS01(1− β)S00 , (2.6)
where Sxy counts the number of edges for which Xnm = x and Ynm = y. For
instance, S10 is the number of false positives.
Likelihood for protein-DNA binding data. Here, we consider a single data
set YN×K obtained with data type T aimed at measuring transcription factor-
DNA binding events (TF). Rather than hybridization levels (for ChIP-chip)
or peaks (for ChIP-seq), we model the p-values corresponding to binding
events, which makes our model independent of the technology used to detect
the binding event. We develop a mixture model for the p-values, directly.
Given the pathway, X, we expect to see a small p-value for protein n binding
nucleotide sequence m whenever the edge Xnm is present. On the contrary,
the p-values are uniformly distributed under the null hypothesis of no binding
events, Xnm = 0. We evaluate
Ltf (Y | X, γ) =
∏
n,m
[
Uniform (Ynm) · 1(Xnm = 0)
+ Beta (Ynm | γ, 1) · 1(Xnm = 1)
]
, (2.7)
where 0 < Ynm < 1 (p-value), and 0 < γ < 1. See a related beta-uniform
mixture model introduced by Pounds and Morris (2003) in the context of
multiple testing for differential expression.
Likelihood for knock-out data. Here we consider a data set YM×N , where
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Ymn is the log-two-fold change in expression of gene n, when gene m is knocked
out. Let Zmn be a binary variable representing the existence of a directed
path from gene n to gene m, through a transcription factor. While we consider
the set of undirected pathway models, we temporarily impute directionality
using the fact that the cellular signal should flow from the cytoplasm to the
nucleus. We model the knockout data as a mixture of normals:
Lko(Y | X, σ0, σ1) = (2.8)
=
∏
n,m
Normal (Y |0, σ1) 1[Zmn] + Normal (Y |0, σ0) 1(1− Zmn)
The standard deviations for change in expression are represented by σ0 (when
there is no path between the knockout and a target) and σ1 (there is a path).
The assumption is that σ1 > σ0 since we expect a larger change in expression
of n for knockout m when n and m are connected in the pathway.
Likelihood for gene co-expression data. Here, we consider a single data
set YN×N aimed at measuring gene expression. Rather than hybridization
levels (for microarrays) or the number of reads (for mRNA sequencing), we
model correlations among the profiles of pairs of genes, which again makes
our model independent of the details of the measurement technology. We
develop a mixture model for the correlations, directly. Given the pathway,
X, we expect to see correlation between the expression profiles of two genes
whenever they are co-regulated. Similarly to Scha¨fer and Strimmer (2005b),
we use a mixture model for the distribution of the sample correlation coeffi-
cient ρˆ = y of the form
Lexpr(Y | X, δ, κ) =
∏
n<m
[
P0(Ynm | κ) · 1(Xnm = 0) +
P1(Ynm | δ, 1) · 1(Xnm = 1)
]
(2.9)
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When Xnm = 0, we expect the two gene profiles to be uncorrelated. Differ-
ently from Scha¨fer and Strimmer (2005b), however, we chose a distribution
that puts more emphasis on higher correlation if we see an edge in the model,
Xnm = 1, using a one-parameter beta distribution,
P1(y|δ) = Beta (y | δ, 1). (2.10)
Likelihood for node attributes data. Here, we consider a single data set
YM×N that lists node-specific attributes such as protein domains from PFAM
(Punta et al., 2012) and SMART (Schultz et al., 1998; Letunic et al., 2012)
databases, and differential phosphorylation data (Gruhler et al., 2005). We
develop novel techniques to model protein attributes. Specifically, we model
the likelihood of an attribute conditional on the given pathway X. We term
our models for node attributes “relation regression.” For differential phos-
phorylation data, YN×1,
Lnode(Y | X,λ, σ) = (2.11)
=
∏
n
Normal
(
Yn | λ0 + λ1
∑
m6=n Ym1(Xnm = 1)∑
m 6=n 1(Xnm = 1)
, σ2
)
In other words, the differential phosphorolation, Yn, is assumed to be linearly
related to the mean differential phosphorolation of the neighbors of node n.
Similarly, for the protein domain data, DN×K , we use an auto-logistic regres-
sion to model the data. Specifically, for Dnk, a binary variable indicating the
presence of domain k in protein n,
Lnode(D | X,λ) =
∏
nk
PDnknk (1− Pnk)(1−Dnk) (2.12)
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where
Pnk = logit
−1
(
λ0 +
∑
j
λj1
[∑
m 6=n
Dmj1(Xnm = 1) > 0
])
Here, logit(Pnk) is linearly related to the presence of domains in neighboring
genes. In both the normal and logistic regression cases, we fit the regression
coefficients, ~λ, using our initial pathway hypothesis. In the logistic model, we
use a weakly-informative Cauchy prior for the coefficients (Gelman, 2008).
This controls for any overfitting and separation problems that may occur.
Prior distribution on the space of pathway models. In this study our focus
lies on assessing the extent to which the data support a pathway model X.
We choose a block model prior P (X) over binary matrices of size N × N
with edge density fixed by compartment. In general, any informative prior
distribution on graphs could be used here to encode biological knowledge
(Isci et al., 2013; Mukherjee and Speed, 2008).
3 Analysis of the pheromone response path-
way in S. cerevisiae
To demonstrate the efficacy of our approach, we examine the pheromone
response MAPK pathway in the yeast S. cerevisiae. It offers the opportunity
to combine a large collection of datasets with a solid understanding of the
pathway structure. The pheromone pathway is the subject of intense research
efforts in computational biology as well as experimental biology (Hara et al.,
2012; Scott et al., 2006; Kofahl and Klipp, 2004) and shows cross-talk to
other MAPK pathways (Nagiec and Dohlman, 2012; McClean et al., 2007;
Gat-Viks and Shamir, 2007).
Initial pathway construction. To start our analysis in a way relevant
to refining and extending existing knowledge of signaling pathways, we ex-
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tracted a model of the pheromone response pathway from the summary of
MAPK pathways (sce04010) in the database KEGG (Kanehisa and Goto,
2000) and combined it with known transcription factor (TF) targets from
two independent studies (Simon et al., 2001; Ren et al., 2000).
We split the pathway into three parts: the membrane compartment con-
taining the receptor proteins, the cytoplasm compartment containing the
MAPK cascade to activate the transcription factors (TF), and the nuclear
compartment containing the TFs and their targets. Figure 1-A depicts the
pathway hypothesis. Proteins mediating between two compartments (like
TFs) are contained in two sub-graphs and marked by grey boxes. TF targets
that are also members of other compartments are indicated in bold.
3.1 Exploratory data analysis of individual data types
Before inferring the full model from all data, we explored the information
content in each type of data individually.
Protein-protein interactions (PPI). We compared data from several com-
plementary high-throughput assays, all available from BioGRID (Stark et al.,
2006) as well as a literature-curated dataset (Reguly et al., 2006). We ana-
lyzed the overlap between the protein interactions and the pathway hypoth-
esis of Fig 1-A. None of the datasets are informative for the membrane and
nuclear compartments. Surprisingly, in the cytoplasm compartment we found
that all of the high-throughput datasets show only ≤ 3 interactions between
any of the proteins in the pathway. The situation was very different for the
literature-curated data. Here, 45 interactions in the cytoplasm compartment
covered 22 out of the 28 edges there (sensitivity > 78%, specificity > 87%,
see Fig 1-B1).
TF-DNA binding data. We used the transcription factor binding data of
(Harbison et al., 2004), which is independent of our definition of TF targets in
the pathways hypothesis. The ROC in Figure 1-B4 shows very clear signal to
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distinguish the targets posited in the biological model from all other pathway
genes.
Co-expression data. For gene expression data, we examined datasets in
which the pathway genes showed a significant difference in correlation struc-
ture from all other yeast genes (using the SPELL algorithm of (Hibbs et al.,
2007)) resulting in 20 datasets from 15 publications (including Roberts et al.,
2000; Gasch et al., 2000; Brem and Kruglyak, 2005). Figure 1-B2 shows ROCs
for predicting edges in the nuclear compartment for all datasets (grey lines)
and the concatenated data (black line). No curve improves much on random
prediction (the main diagonal). The reason is biological: Because expression
data are a poor surogate for protein activity, TFs are often less well corre-
lated to their targets than the targets are between each other (Figure 1-B3).
For STE12, which regulates itself, all correlation coefficients exhibit a strong
trend towards high positive correlation. Whereas MCM1, which is not self-
regulating, is far less strongly correlated to its targets than the targets are
between each other. Thus, in general it is more informative to use the cor-
relation between targets for inference, which is consistently high whether or
not a TF is transcriptionally regulated itself.
Gene perturbation data. Paths in the graph are visible in cause-effect
datasets (Hughes et al., 2000; Roberts et al., 2000). We find only very small
effects of perturbations in the pathway on the expression of members of the
membrane and cytoplasm compartment including TFs. Figure 1-C summa-
rizes this result for the Roberts et al. (2000) data. Very similar results were
found for the Hughes et al. (2000) data. The four boxes correspond to the
three compartments plus TFs. In each box, a vertical line corresponds to
a perturbation in the pathway (some replicated). The dots show the fold-
changes of the pathway genes in this compartment. Only in the nuclear
compartment are wide-spread large fold-changes visible. This observation
motivates the construction of our likelihood around the presence of paths
between the knockout and genes in the nuclear compartment (see section 2).
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In this way, when the knockout is far enough upstream, there is information
about edges in the cytoplasm as well, even if the proteins there show no effect
on the transcriptional level.
Protein phosphorylation. A first example of node information is protein
phosphorylation. The study of Gruhler et al. (2005) assessed differential
phosphorylation of proteins in response to pheromone. Figure 1-D1 shows the
log-ratios between the pheromone treated and untreated conditions. Almost
all proteins of the pheromone pathway measured by Gruhler et al. (2005) are
up-regulated, which makes sense for a kinase cascade. The phosphorylation
we observe for proteins corresponding to genes only attributed to the nuclear
compartment in our model must be due to other kinase pathways in the cell.
We further assessed to what extent the differential phosphorylation is cor-
related with the pathway model by fitting an auto-logistic regression. As a
measure of correlation we computed the variance explained, R2 = 0.76, using
the bootstrap . The variance explained by the auto-logistic regression was
found statistically significant, when compared to the correlation of differen-
tial phosphorylation with randomized pathway models, p ≈ 0.062, and with
randomized protein permutations on the true pathway model, p ≈ 0.059.
Protein domains. A second example of node information are protein do-
mains. We retrieved protein domains from PFAM (Punta et al., 2012) and
SMART (Letunic et al., 2012). First, we sought to quantify which domains,
if any, were over-represented in the set of proteins involved in the complete
pheromone response pathway as well as in each compartment, in turn. Fig-
ure 1-D2 lists the domains that were found to be over-represented in the
complete pathway and in the cytoplasm; darker shades of gray indicate a
more significant p-value for the over-representation test.
Second, we sought to quantify to what extent the presence or absence of
specific protein domains in proteins interacting with a given protein, P , was
informative about the presence or absence of the same domain in such protein,
P . This analysis was carried out using auto-logistic models, which summa-
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rize the informativeness of protein domains between interacting proteins on
average, across all proteins in a given pathway. We fit auto-logistic regres-
sions using each protein P in the cytoplasm compartment of the pheromone
response pathway as data point, and the presence or absence of domains D1:K
in any one protein among those interacting with P as covariates.
We fit multivariate models, which assume that the presence or absence of
either the same or complementary domains is a factor that facilitates protein
physical interactions. The two tables in 1-D3 summarize the goodness of
fit of the multivariate models, and report bootstrap p-values to assess the
significance of the AIC scores. Figure 1-D3 shows the p-values obtained
by fitting the multivariate auto-logistic regression to randomized pathway
models. The domains identified by the multivariate models as putatively
carrying signal about the pheromone pathway in the cytoplasm overlap with
the domains identified by the over-representation analysis above; namely,
P21 rho-binding domains, S-TKc domains, and tyrosine-specific catalytic
domains.
In summary, node attributes of the proteins involved in the pheromone
response pathways are informative about mechanistic elements of the kinase
cascade, across cellular localizations and in the cytoplasm. These findings
suggest that integrating node attributes such as protein domains and cellular
localization should increase the likelihood of pathway models that encode real
biological signal about the inner working of a target pathway.
Data Integration. The previous results suggest that some datasets are
indeed more informative in certain cellular locations. For example, protein
interactions can explain wide parts of the kinase cascade in the cytoplasm,
while co-expression is very strong for TF targets. However, no dataset is
informative in all compartments: Neither protein interactions nor knockout
data can explain a complete pathway. The pheromone response pathway is
an archetypical MAPK pathway, so we expect these observations also to be
valid for other MAPK and signaling pathways. These results suggest that the
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compartment-specific modeling approach we take here is sensible. As a proof
of concept, we use the results of exploratory data analysis to heuristically
construct the compartment map, C (Table 1). Ultimately, we hope to infer
the compartment map in a statistically principled way.
3.2 Validation of the integrated analysis
We evaluated how well the joint model, which combines all the complemen-
tary data types discussed above, supports the pathway hypothesis in Section
3 by sampling 1000 possible pathways using MCMC and tabulating the pos-
terior probabilities over the edges.
The logistic regression model for domain data may be subject to over-
fitting and separation. This can occur since there are many different protein
domains present, yet the frequency of any single domain is fairly low. To
mitigate this issue, we used a Cauchy prior on the coefficients for the suto-
logistic regression, which is a sensible default prior for this model (Gelman,
2008). Since the domain information in the pheromone pathway is relatively
sparse, we also collected protein domain data from other MAPK pathways
and used the hypothesized structure of those pathways to help learn the
regression coefficients. Figure 1A includes the posterior probabilities for the
edges in our initial hypothesis.
Table 1: The compartment map, C, associates pathway compartments with
those data types that are informative for such compartments. Prior informa-
tion is informative for all compartments.
Membrane Cytoplasm Nucleus
PPI 1 1 0
TF 0 0 1
Expr 0 0 1
Kout 0 1 1
Node 0 1 0
Prior 1 1 1
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We also used a leave-one-out strategy to evaluate the predictive power
of our model. We ran 37 separate simulations where each node was in turn
left out of the training pathway. The edges connected to this node were
propagated to the neighboring nodes of the left-out node. We left out the
nodes rather than edges, because specifically leaving out edges is equivalent
to assuming that we know there is no edge present. We needed to construct
our model in a way that encodes ignorance about the presence of an edge.
Leaving out the nodes, instead of the edges, is one way of being agnostic
about the presence of edges attached to that node. Only the coefficients in
the auto-logistic regression were learned from the pathway hypothesis, so only
the node likelihoods were affected. Table 2 shows the posterior probabilities
for edges (under simulations in which a node was removed from the prior
hypothesis pathway). This table presents posterior probabilities for edges
Table 2: Posterior edge probabilities for leave-one-out trials involving edges
in knockout experiments. Since we use a leave-node-out scheme, there are
two posterior probabilities for an edge (corresponding to which of the two
node endpoints were left out for that particular simulation).
Real data In Silico
Min Average Max Min Average Max
STE11/STE7 0.01 0.01 0.01 0.26 .31 0.36
MCM1/STE2 0.00 0.01 0.02 0.03 0.12 0.2
MF(ALPHA)1/STE2 0.00 0.00 0.01 0.01 0.19 0.36
FUS1/STE12 0.80 0.83 0.87 0.39 0.66 0.92
CDC42/STE18 0.00 0.00 0.00 0.00 0.16 0.31
FUS3/STE12 0.01 0.01 0.01 0.01 0.10 0.19
STE5/STE7 0.13 0.13 0.13 0.00 0.14 0.27
BNI1/CDC42 0.49 0.55 0.61 0.20 0.24 0.28
FAR1/MCM1 0.00 0.00 0.00 0.24 0.26 0.27
FAR1/STE12 0.00 0.00 0.00 0.00 0.37 0.73
STE12/CHS1 0.80 0.82 0.83 0.01 0.02 0.03
STE12/FIG2 0.84 0.84 0.85 0.04 0.24 0.43
MCM1/AGA1 0.10 0.23 0.37 0.07 0.17 0.27
STE12/FIG1 0.00 0.00 0.00 0.42 0.70 0.98
STE12/CIK1 0.83 0.84 0.85 0.94 0.96 0.98
STE12/KAR5 0.83 0.83 0.84 0.23 0.30 0.37
STE12/GIC2 0.83 0.83 0.84 0.12 0.54 0.95
MCM1/SWI4 0.00 0.00 0.00 0.16 0.29 0.41
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involved in knockout experiments.
Lastly, Figure 2 shows the precision-recall curve for our model, by com-
partment. For the membrane compartment, only the PPI data is informative,
and weakly so. Thus, it performs the most poorly, although there are also
by far the fewest genes in this compartment. By contrast, the nuclear and
cytoplasm compartments both have high precision and recall.
Figure 2: Precision/Recall curves overall and by compartment for the MAPK pathway
(left) and simulated data (right). In truth, the membrane compartment, which has the
fewest genes, performs poorly because only the PPI dataset is (weakly) informative there.
The simulated data curve reflects the average Precision/Recall over 30 simulated datasets.
3.3 Inferring cross-talk with other pathways
With our model, we are also able to identify possible cross-talk between
pathways. In this paper, we focus on the pheromone response pathway,
but our model can easily be used on other pathways, as long as we specify
the relevant genes and transcription factors, and their corresponding cellular
locations.
For instance, the MAPK pathway consists of the pheromone sub-pathway,
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as well as hypotonic shock, osmolarity and starvation sub-pathways. The
degree of interaction between components of these MAPK pathways is not
currently known. To identify cross-talk between the pheromone pathway and
other MAPK pathways, we can simply include a new set of genes from the
other sub pathways and fit the model as usual. The results for the cross-talk
evaluations are displayed in Table 3.
Table 3: Number of inferred edges between the pheromone pathway and
one of the other three sub-pathways with posterior probabilities above 0.3.
osmolarity hypotonic starvation
cytoplasm-cytoplasm 16 25 11
cytoplasm-membrane 12 17 8
cytoplasm-nucleus 22 17 3
cytoplasm-tf 0 2 3
membrane-membrane 2 2 2
membrane-nucleus 19 13 3
membrane-tf 0 1 2
nucleus-nucleus 4 7 0
nucleus-tf 1 6 10
tf-tf 0 0 2
3.4 Performance assessment on simulated data
We also fit the model to in silico data. We constructed the “true pathway” to
match the hypothesized MAPK pheromone pathway of Figure 1A. That is,
we fixed a pathway with the matching nodes and edges. We then generated
in silico datasets from the models specified in Section 2. The one exception
is the data generation for the node data.
Here, we generate the presence of domains in a way such that short
chains in the pathway are more likely to share domains than are random
non-neighboring nodes. Specifically, we randomly chose chains of length 1 to
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4 and added a common “domain” to every node in that chain. In this way,
the domain data realistically reflect the notion that genes sharing common
protein domains are more likely to interact.
The leave-one-out results are given in Table 2 beside the results for the
true data. Figure 2 shows the precision-recall curve averaged over 30 simu-
lated datasets. As in the true data analysis, the results demonstrate high pre-
cision and recall, expecially in the “nucleus” and “cytoplasm”. The “mem-
brane” shows the worst precision-recall because we have the fewest informa-
tive data types there, but when simulating from the true data generating
process, we still do quite well.
4 Discussion
The proposed methodology achieves fairly strong predictive power by in-
tegrating data in a compartment specific way. Importantly, we are able to
evaluate how each data type contributes to the overall likelihood of any edge.
Since each data type independently contributes to the probability of an edge,
we can compute the fraction of the overall likelihood difference (between an
edge and no edge) that is due to a particular data type. In this way our
framework provides information about which parts of a pathway hypothesis
are not well supported by available data (see Figure 3).
In addition, our methodology can identify if a particular data type tends
to disagree with the other data types for sets of edges. This could indicate
whether or not a data type is at all useful for modeling edges in a particular
cellular location. Thus, it may be possible to do inference on the com-
partment map from Table 1, rather than fix it a priori. Alternatively, this
information can be used to check the validity of the individual data models
of Section 2 .
There are some open statistical issues that could be addressed in future
work. One problem with the node data, is that the protein domains are di-
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verse and sparse. While there is evidence of signal here, there is an over-fitting
problem. With more domain data, or perhaps broader domain categories, we
Figure 3: Percentages of differential likelihood (presence vs. absence of an
edge) due to specific data types, by compartment. Node data contribute the
most in the cytoplasm (center), whereas TF-DNA binding data contribute
the most in the nucleus (right).
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may be able to learn more from the prior pathway. If this was the case, the
leave-one-out results in the cytoplasm might improve significantly. This is
evident from our results which show how borrowing domain information from
other MAPK sub-pathways significantly improved the posterior probabilities
of edges in the leave-one-out simulations.
We also noticed that most of the knockouts in the gene perturbation
data set we used were generally downstream. If the knockouts were further
upstream from perturbed genes in the nucleus, then we could learn about the
possible presence of edges in a path between the knockout and other genes.
Lastly, we divided the pathway into its three main compartments: mem-
brane, cytoplasm and nucleus. However, in future work, we hope to divide
the pathway more finely into the over two dozen cellular components speci-
fied by the gene ontology (GO) for the yeast S. Cerevisae. By dividing the
pathway into more compartments, we would also have a greater degree of
control over which data types are used in various parts of the cell.
4.1 Concluding remarks
In this paper we introduced a technique for refining cellular pathway models
by integrating heterogeneous data sources in a compartment specific way
and explicitly included node properties in our model. Our case-study results
indicate that this model can be useful for discovering new components or
cross-talk with other pathways. Our powerful and flexible pathway modeling
framework can be easily extended and modified to include additional and
novel datasets.
A Supplementary results
In this appendix we present more details about the simulation results.
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Figure 4: Log posterior probabilities for edges that were not in the hypothesis path-
way. The vast majority of non-edges have small posterior probability (third quantile at
0.02). However, there are a few highly probable edges, which may indicate previously
undiscovered interactions.
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Gene 1 Gene 2 Prob
1 STE12 DIG2 0.60
2 STE12 FUS1 0.39
3 STE12 FUS3 0.01
4 STE12 FAR1 0.00
5 STE12 MCM1 0.00
6 STE12 FIG2 0.43
7 STE12 FIG1 0.42
8 STE12 CIK1 0.98
9 STE12 GIC2 0.12
10 STE12 AFR1 0.01
11 STE12 KAR5 0.23
12 STE12 CHS1 0.03
13 STE12 AGA1 0.27
14 DIG2 STE12 0.68
15 DIG2 FUS3 0.00
16 STE7 STE11 0.26
17 STE7 STE5 0.21
18 STE7 FUS3 0.26
19 STE11 STE7 0.36
20 STE11 STE20 0.24
21 STE11 STE5 0.00
22 STE20 STE11 0.00
23 STE20 CDC42 0.31
24 STE20 BEM1 0.08
25 STE20 STE5 0.00
26 CDC42 STE20 0.00
27 CDC42 BNI1 0.28
28 CDC42 STE4 0.24
29 CDC42 STE18 0.31
30 CDC42 BEM1 0.47
31 CDC42 CDC24 0.50
32 FUS1 STE12 0.98
33 BNI1 CDC42 0.20
34 MFA1 STE3 0.34
35 MFA1 MCM1 0.07
36 STE2 MF(ALPHA)2 0.01
37 STE2 GPA1 0.35
38 STE2 MCM1 0.20
39 STE3 MFA1 0.30
40 STE3 GPA1 0.13
41 MF(ALPHA)2 STE2 0.36
42 GPA1 STE2 0.01
43 GPA1 STE3 0.14
44 GPA1 STE4 0.14
45 GPA1 STE18 0.12
46 STE4 CDC42 0.22
47 STE4 GPA1 0.14
48 STE18 CDC42 0.00
49 STE18 GPA1 0.13
50 BEM1 STE20 0.36
51 BEM1 CDC42 0.18
52 CDC24 CDC42 0.18
53 STE5 STE7 0.00
54 STE5 STE11 0.00
55 STE5 STE20 0.00
56 STE5 FUS3 0.00
57 FUS3 STE12 0.19
58 FUS3 DIG2 0.21
59 FUS3 STE7 0.22
60 FUS3 STE5 0.05
Gene 1 Gene 2 Prob
61 FUS3 MSG5 0.05
62 FUS3 FAR1 0.00
63 MSG5 FUS3 0.00
64 FAR1 STE12 0.73
65 FAR1 FUS3 0.27
66 FAR1 MCM1 0.27
67 MCM1 STE12 0.00
68 MCM1 MFA1 0.15
69 MCM1 STE2 0.03
70 MCM1 FAR1 0.24
71 MCM1 SWI4 0.41
72 MCM1 MFA2 0.20
73 MCM1 AGA1 0.27
74 MCM1 ALK1 0.15
75 MCM1 SWI5 0.38
76 MCM1 CDC20 0.34
77 SWI4 MCM1 0.16
78 MFA2 MCM1 0.19
79 FIG2 STE12 0.04
80 FIG1 STE12 0.98
81 CIK1 STE12 0.94
82 GIC2 STE12 0.95
83 AFR1 STE12 0.02
84 KAR5 STE12 0.37
85 CHS1 STE12 0.01
86 AGA1 STE12 0.00
87 AGA1 MCM1 0.07
88 ALK1 MCM1 0.24
89 SWI5 MCM1 0.13
90 CDC20 MCM1 0.18
Table 4: Posterior edge probabilities.
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